<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-11-03">3 November 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Rosa</forename><surname>Planells-Cases</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Leibniz-Institut für Molekulare Pharmakologie (FMP)</orgName>
								<orgName type="institution">Max-Delbrück-Centrum für Molekulare Medizin (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Darius</forename><surname>Lutter</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Leibniz-Institut für Molekulare Pharmakologie (FMP)</orgName>
								<orgName type="institution">Max-Delbrück-Centrum für Molekulare Medizin (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Charlotte</forename><surname>Guyader</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Division of Molecular Oncology</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nora</forename><forename type="middle">M</forename><surname>Gerhards</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Institute of Animal Pathology</orgName>
								<orgName type="department" key="dep2">Vetsuisse Faculty</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<settlement>Bern</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Florian</forename><surname>Ullrich</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Leibniz-Institut für Molekulare Pharmakologie (FMP)</orgName>
								<orgName type="institution">Max-Delbrück-Centrum für Molekulare Medizin (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Deborah</forename><forename type="middle">A</forename><surname>Elger</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Leibniz-Institut für Molekulare Pharmakologie (FMP)</orgName>
								<orgName type="institution">Max-Delbrück-Centrum für Molekulare Medizin (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Asli</forename><surname>Kucukosmanoglu</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Division of Molecular Pathology</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Guotai</forename><surname>Xu</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Division of Molecular Pathology</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Felizia</forename><forename type="middle">K</forename><surname>Voss</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Leibniz-Institut für Molekulare Pharmakologie (FMP)</orgName>
								<orgName type="institution">Max-Delbrück-Centrum für Molekulare Medizin (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">S</forename><surname>Momsen</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Leibniz-Institut für Molekulare Pharmakologie (FMP)</orgName>
								<orgName type="institution">Max-Delbrück-Centrum für Molekulare Medizin (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tobias</forename><surname>Stauber</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Leibniz-Institut für Molekulare Pharmakologie (FMP)</orgName>
								<orgName type="institution">Max-Delbrück-Centrum für Molekulare Medizin (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Vincent</forename><forename type="middle">A</forename><surname>Blomen</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Division of Biochemistry</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Daniel</forename><forename type="middle">J</forename><surname>Vis</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Division of Molecular Carcinogenesis</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lodewyk</forename><forename type="middle">F</forename><surname>Wessels</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Division of Molecular Carcinogenesis</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thijn</forename><forename type="middle">R</forename><surname>Brummelkamp</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Division of Biochemistry</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Piet</forename><surname>Borst</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Division of Molecular Oncology</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sven</forename><surname>Rottenberg</surname></persName>
							<email>sven.rottenberg@vetsuisse.unibe.ch</email>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Institute of Animal Pathology</orgName>
								<orgName type="department" key="dep2">Vetsuisse Faculty</orgName>
								<orgName type="institution">University of Bern</orgName>
								<address>
									<settlement>Bern</settlement>
									<country key="CH">Switzerland</country>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Division of Molecular Pathology</orgName>
								<orgName type="institution">The Netherlands Cancer Institute</orgName>
								<address>
									<settlement>Amsterdam</settlement>
									<country key="NL">The Netherlands</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Thomas</forename><forename type="middle">J</forename><surname>Jentsch</surname></persName>
							<email>jentsch@fmp-berlin.de</email>
							<affiliation key="aff0">
								<orgName type="department">Leibniz-Institut für Molekulare Pharmakologie (FMP)</orgName>
								<orgName type="institution">Max-Delbrück-Centrum für Molekulare Medizin (MDC)</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="institution" key="instit1">NeuroCure Cluster of Excellence</orgName>
								<orgName type="institution" key="instit2">Charité Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department">Institute of Chemistry and Biochemistry</orgName>
								<orgName type="institution">Freie Universitaet Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Subunit composition of VRAC channels determines substrate specificity and cellular resistance to Pt-based anti-cancer drugs</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2015-11-03">3 November 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">9340F1562D668D552579499D70467DC7</idno>
					<idno type="DOI">10.15252/embj.201592409</idno>
					<note type="submission">Received 30 June 2015 | Revised 4 October 2015 | Accepted 5 October 2015 |</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:23+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>chloride channel</term>
					<term>haploid cell screen</term>
					<term>swelling-activated</term>
					<term>VSOAC</term>
					<term>VSOR Subject Categories Autophagy &amp; Cell Death</term>
					<term>Cancer</term>
					<term>Membrane &amp; Intracellular Transport</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Although platinum-based drugs are widely used chemotherapeutics for cancer treatment, the determinants of tumor cell responsiveness remain poorly understood.</s><s>We show that the loss of subunits LRRC8A and LRRC8D of the heteromeric LRRC8 volume-regulated anion channels (VRACs) increased resistance to clinically relevant cisplatin/ carboplatin concentrations.</s><s>Under isotonic conditions, about 50% of cisplatin uptake depended on LRRC8A and LRRC8D, but neither on LRRC8C nor on LRRC8E.</s><s>Cell swelling strongly enhanced LRRC8dependent cisplatin uptake, bolstering the notion that cisplatin enters cells through VRAC.</s><s>LRRC8A disruption also suppressed drug-induced apoptosis independently from drug uptake, possibly by impairing VRAC-dependent apoptotic cell volume decrease.</s><s>Hence, by mediating cisplatin uptake and facilitating apoptosis, VRAC plays a dual role in the cellular drug response.</s><s>Incorporation of the LRRC8D subunit into VRAC substantially increased its permeability for cisplatin and the cellular osmolyte taurine, indicating that LRRC8 proteins form the channel pore.</s><s>Our work suggests that LRRC8D-containing VRACs are crucial for cell volume regulation by an important organic osmolyte and may influence cisplatin/carboplatin responsiveness of tumors.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>The platinum-containing drugs cisplatin, carboplatin, and oxaliplatin are among the most successful drugs used for treating cancer <ref type="bibr" target="#b28">(Kelland, 2007)</ref>.</s><s>Pt drugs introduce covalent adducts in DNA which eventually cause cell death.</s><s>Tumor cells treated with therapeutic doses of Pt drugs probably die predominantly by mitotic catastrophe/necrosis <ref type="bibr" target="#b2">(Borst et al, 2001;</ref><ref type="bibr" target="#b7">Brown &amp; Attardi, 2005)</ref>.</s><s>Attempts to link Pt drug sensitivity to apoptosis remain prominent <ref type="bibr" target="#b54">(Speirs et al, 2011)</ref>, however, even though the induction of apoptosis by high drug concentrations has been shown to be due to a cytoplasmic offtarget effect of Pt drugs <ref type="bibr" target="#b37">(Mandic et al, 2003;</ref><ref type="bibr" target="#b1">Berndtsson et al, 2007;</ref><ref type="bibr" target="#b16">Fayad et al, 2009)</ref>.</s></p><p><s>In cultured cells, the induction of apoptosis by cisplatin and other drugs such as staurosporine is characterized by an early cell shrinkage denominated apoptotic volume decrease (AVD) which is followed by other apoptotic hallmarks like the activation of caspases and DNA fragmentation.</s><s>AVD and the induction of apoptosis could be inhibited by blockers of the ubiquitously expressed volume-regulated anion channel VRAC (also known as VSOR or VSOAC) <ref type="bibr" target="#b36">(Maeno et al, 2000;</ref><ref type="bibr" target="#b24">Ise et al, 2005;</ref><ref type="bibr" target="#b41">Okada et al, 2006;</ref><ref type="bibr" target="#b32">Lang &amp; Hoffmann, 2012)</ref>.</s><s>Being closed under resting conditions, VRAC opens upon cell swelling and releases chloride and organic osmolytes in the course of regulatory volume decrease (RVD).</s><s>The effect of VRAC blockers on drug-induced apoptosis was attributed to a loss of VRAC-dependent AVD <ref type="bibr" target="#b36">(Maeno et al, 2000)</ref>.</s><s>However, the blockers used to substantiate a role of VRAC in apoptosis are all non-specific, and the notion that AVD facilitates apoptosis is controversial <ref type="bibr" target="#b44">(Orlov et al, 2013)</ref>.</s><s>VRAC has been characterized biophysically and physiologically for decades, but the failure to identify the underlying proteins <ref type="bibr" target="#b40">(Okada, 1997;</ref><ref type="bibr" target="#b46">Pedersen et al, 2015)</ref> precluded conclusive genetic and biochemical studies.</s><s>Only recently, LRRC8 heteromers were identified as essential VRAC components.</s><s>LRRC8A is an obligatory VRAC subunit <ref type="bibr" target="#b49">(Qiu et al, 2014;</ref><ref type="bibr" target="#b58">Voss et al, 2014)</ref>, but it needs at least one other LRRC8 homolog (LRRC8B, LRRC8C, LRRC8D, or LRRC8E) to mediate volume-activated anion currents <ref type="bibr">(I Cl,vol )</ref> or to release organic osmolytes like taurine <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>.</s><s>A weak homology to pannexins suggests that LRRC8 proteins may assemble to hexameric channels <ref type="bibr">(Abascal &amp; Zardoya, 2012)</ref>.</s><s>The formation of different LRRC8 heteromers indicates that there are several different VRACs that may vary in properties and tissue distribution.</s><s>For instance, the subunit composition of LRRC8 heteromers might specify the channel's preference for chloride over taurine or vice versa.</s><s>Such a scenario would support the contentious notion <ref type="bibr" target="#b30">(Lambert &amp; Hoffmann, 1994;</ref><ref type="bibr" target="#b55">Stutzin et al, 1999;</ref><ref type="bibr" target="#b50">Shennan, 2008)</ref> that VRAC is molecularly distinct from a postulated volume-stimulated organic osmolyte/ anion channel VSOAC <ref type="bibr" target="#b27">(Jackson &amp; Strange, 1993)</ref>.</s><s>However, the impact of specific LRRC8 subunits on VRAC's selectivity has not yet been investigated.</s></p><p><s>An unbiased genomic screen now revealed that the loss of either of two VRAC subunits, LRRC8A or LRRC8D, increased resistance against carboplatin and cisplatin.</s><s>This finding can be largely explained by an unsuspected role of VRAC in drug transport.</s><s>This transport required the obligatory channel subunit LRRC8A and also depended on LRRC8D, a subunit that strongly increased VRAC's permeability to cisplatin/carboplatin.</s><s>Exposure to staurosporine revealed an additional, drug uptake-independent, but possibly AVDrelated effect of LRRC8A on drug-induced apoptosis.</s><s>Moreover, LRRC8D increased VRAC's permeability to taurine, and cells lacking this subunit showed reduced cell volume regulation.</s><s>Our work uncovers a novel role of VRAC in cisplatin and carboplatin uptake and resistance, identifies LRRC8A/LRRC8D-containing VRACs as physiologically important organic osmolyte channels, and reveals differences in substrate selectivity and pharmacology between differently composed VRACs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A genomewide screen identifies LRRC8A and LRRC8D as mediators of carboplatin and cisplatin resistance</head><p><s>To identify genes affecting platinum drug sensitivity, we performed genomewide loss-of-function screens of haploid KBM7 cells that were subjected to insertional mutagenesis using a gene-trap virus <ref type="bibr" target="#b11">(Carette et al, 2009)</ref>  <ref type="bibr">(Fig 1A)</ref>.</s><s>Cells resisting exposure to 7 lM carboplatin for three weeks showed a significant enrichment of insertions in the LRRC8D and LRRC8A genes (Fig <ref type="figure" target="#fig_0">1B</ref> and Appendix Table <ref type="table">S1</ref>).</s><s>Most sense insertions were localized in introns upstream of the ORF-containing exon 3 (Fig <ref type="figure" target="#fig_0">1C</ref>).</s><s>These positions are consistent with gene-inactivating mutations.</s><s>Two LRRC8Ddeficient KBM7 clones, which display reduced blasticidin S uptake <ref type="bibr" target="#b35">(Lee et al, 2014)</ref> and which lack the LRRC8D protein (Fig EV1 <ref type="figure">)</ref>, were indeed more resistant to both carboplatin and cisplatin, but not to the larger compound oxaliplatin <ref type="bibr">(Fig 1D and Appendix Table</ref>  <ref type="table">S2</ref>).</s><s>Likewise, KBM7-derived haploid HAP1 cells <ref type="bibr" target="#b13">(Carette et al, 2011)</ref> were resistant to carboplatin and cisplatin, but not to oxaliplatin, when LRRC8A or LRRC8D was disrupted <ref type="bibr">(Fig EV2)</ref>.</s><s>Hence, two genes, LRRC8A and LRRC8D, affected carboand cisplatin sensitivity at drug concentrations that can be achieved in patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Low LRRC8D expression correlates with reduced survival of Pt drug-treated ovarian cancer patients</head><p><s>To determine whether LRRC8A or LRRC8D expression might affect chemotherapy in patients, we examined The Cancer Genome Atlas (TCGA) data collection of ovarian cancer patients who were treated with platinum drugs.</s><s>We analyzed the survival of patients with a low tumor expression of LRRC8A or LRRC8D versus the remaining patients.</s><s>We used the lower tertile of the distribution of LRRC8A and LRRC8D expressions as cutoff.</s><s>Whereas low LRRC8A expression had no influence on survival (Fig 2A <ref type="figure">)</ref>, patients with a low LRRC8D gene expression in their ovarian cancers displayed a significantly reduced survival <ref type="bibr">(Fig 2B)</ref>.</s><s>Most patients had also received taxane, but disruption of LRRC8A or LRRC8D did not provide resistance against docetaxel <ref type="bibr">(Appendix Fig S1)</ref>.</s><s>To corroborate these results, we investigated the data derived from ovarian cancer patients that were recently published by <ref type="bibr" target="#b45">Patch et al (2015)</ref>.</s><s>Although the available data are derived from fewer patients, also in this analysis a low expression of LRRC8D, but not LRRC8A, correlated with a modest, but significant decrease in survival <ref type="bibr">(Fig 2C and D)</ref>.</s><s>Thus, LRRC8D might also affect platinum drug responses in cancer patients.</s></p><p><s>Pt drug resistance is not strictly correlated with lack of VRAC currents or volume regulation LRRC8A and LRRC8D are subunits of the volume-regulated anion channel VRAC.</s><s>The finding that the loss of LRRC8D conferred drug resistance was surprising because this subunit, unlike LRRC8A, is dispensable for VRAC Cl À currents (I Cl,vol ) in HCT116 cells <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>, a finding we now confirmed for haploid HAP1 and KBM7 cells <ref type="bibr">(Fig 3A and B,</ref><ref type="bibr">Appendix Fig S2)</ref>.</s><s>Hence, Pt drug resistance is not correlated with a loss of VRAC Cl À channel activity.</s></p><p><s>In view of the postulated role of VRAC activation in cisplatininduced cell shrinkage and subsequent apoptotic cell death <ref type="bibr" target="#b36">(Maeno et al, 2000;</ref><ref type="bibr" target="#b41">Okada et al, 2006;</ref><ref type="bibr" target="#b32">Lang &amp; Hoffmann, 2012)</ref>, we explored the role of LRRC8A and LRRC8D in regulatory volume decrease (RVD) that can be determined more reliably than AVD.</s><s>Like I Cl,vol <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>, RVD depended on LRRC8 heteromers because it was similarly impaired in LRRC8A À/À and LRRC8(B,C,D,E) À/À cells that lack LRRC8 isoforms B through E <ref type="bibr">(Fig 3C)</ref>.</s><s>In LRRC8D À/À cells, notwithstanding unchanged I Cl,vol amplitudes <ref type="bibr">(Fig 3A and B;</ref><ref type="bibr" target="#b58">Voss et al, 2014)</ref>, RVD was significantly reduced but not abolished (Fig <ref type="figure" target="#fig_3">3C</ref>).</s><s>Hence, it seems unlikely that LRRC8D disruption protects cells against cisplatin toxicity by impairing VRAC-and AVD-dependent apoptosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>LRRC8-dependent induction of apoptosis by cisplatin and staurosporine</head><p><s>We next measured drug-induced activation of caspase-3 to test whether the induction of apoptosis by staurosporine or high concentrations of cisplatin depends on LRRC8 subunits.</s><s>Cisplatininduced caspase activation was indeed suppressed in LRRC8A  A Outline of the loss-of-function screen.</s><s>B Genes enriched for gene-trap insertions in a carboplatin-selected cell population compared to unselected control cells.</s><s>Circles represent genes and their size corresponds to the number of independent insertions identified in the carboplatin-selected population.</s><s>Genes are ranked on the x-axis based on chromosomal position.</s><s>C Location of gene-trap insertion sites (red arrowheads).</s><s>White boxes indicate the 5 0 -and 3 0 -untranslated regions, and the black boxes show the coding sequence in exons 3 and 4 (LRRC8A) and exon 3 (LRRC8D).</s><s>D Loss of LRRC8D causes resistance to carboplatin and cisplatin, but not to oxaliplatin.</s><s>Survival of parental, vector-transduced, or LRRC8D-deficient GT1 and GT2 KBM7 cells exposed for 96 h to increasing concentrations of cisplatin, carboplatin, and oxaliplatin.</s><s>Swelling-enhanced caspase induction by cisplatin depended on VRAC as it was abolished in LRRC8A À/À and LRRC8 À/À cells.</s><s>It was strongly reduced, but not abolished, in LRRC8D À/À cells (Fig 4B <ref type="figure">)</ref>.</s><s>By contrast, staurosporine-induced caspase activation was not enhanced by hypotonic swelling and was suppressed in LRRC8A À/À , but not in LRRC8D À/À cells (where it was rather increased for unknown reasons) (Fig <ref type="figure" target="#fig_4">4C</ref>).</s><s>Since both I Cl,vol and caspase induction by staurosporine depend on LRRC8A but not LRRC8D, these results are compatible with the hypothesis that VRAC activationdependent AVD facilitates the progression of apoptosis <ref type="bibr" target="#b36">(Maeno et al, 2000;</ref><ref type="bibr" target="#b51">Shimizu et al, 2004)</ref>.</s><s>VRAC activation by pro-apoptotic stimuli was monitored by the quenching of YFP fluorescence by externally added iodide <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>.</s><s>Iodide permeates VRAC efficiently and hence VRAC opening increases YFP quenching rates.</s><s>The slow emergence of an LRRC8A-dependent quenching component upon incubation with 200 lM cisplatin (Fig 5A <ref type="figure">-C</ref>) or 4 lM staurosporine indicated that both drugs slowly activated VRAC (Fig <ref type="figure" target="#fig_5">5E and F</ref>).</s><s>Drug-induced VRAC activation was small compared to that elicited by acute hypotonic cell swelling (Fig 5D <ref type="figure">)</ref>.</s><s>A direct comparison of quenching slopes, however, underestimates the difference in activation because quenching rates after acute exposure to hypotonicity (but not with drug preincubation) also reflect the time course of cell swelling and ensuing VRAC opening (Appendix Fig <ref type="figure" target="#fig_1">S2A and E</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>VRAC mediates cisplatin uptake which depends on LRRC8 subunit composition</head><p><s>The observation that cisplatin activated caspase-3 in WT cells more efficiently when applied in hypotonic medium suggested that cisplatin might enter cells through VRACs.</s><s>Indeed, VRACs not only conduct halide ions, but also organic compounds like taurine, The EMBO Journal Subunit-dependent drug and osmolyte flux via VRAC Rosa Planells-Cases et al glutamate, and blasticidin <ref type="bibr" target="#b27">(Jackson &amp; Strange, 1993;</ref><ref type="bibr">Hyzinski-Garcı ´a et al, 2014;</ref><ref type="bibr" target="#b35">Lee et al, 2014;</ref><ref type="bibr" target="#b49">Qiu et al, 2014;</ref><ref type="bibr" target="#b58">Voss et al, 2014)</ref>.</s><s>Importantly, early studies on a variety of cultured cell lines have led to the conclusion that cisplatin/carboplatin uptake involves two components: About half the drug enters cells by passive diffusion through the plasma membrane and the other half via a protein component, possibly a channel (reviewed by <ref type="bibr" target="#b19">Gately &amp; Howell, 1993)</ref>.</s><s>We therefore measured the cellular accumulation of Pt-based drugs by determining Pt concentrations in extracts of cells of various LRRC8 genotypes.</s><s>Under isotonic conditions, drug uptake performed at therapeutic carboplatin concentrations (7 lM) by drug-resistant LRRC8D À/À KBM7 cell clones was indeed reduced ~twofold compared to control <ref type="bibr">(Fig 6A)</ref>.</s><s>The effect of VRAC subunits in Pt drug uptake was explored in detail for cisplatin in HEK and HCT116 cells of different LRRC8 genotypes.</s><s>The underlying uptake processes did not saturate with cisplatin concentrations up to 400 lM in both WT and LRRC8A À/À cells (Fig EV3 <ref type="figure">)</ref>, allowing us to use concentrations exceeding therapeutic levels to increase the sensitivity of the assay.</s><s>When uptake was performed over several hours under isotonic conditions, cisplatin accumulation was reduced by roughly 70 and 50% upon disruption of LRRC8A or LRRC8D, respectively (Fig 6C <ref type="bibr">(HEK cells),</ref><ref type="bibr">Fig EV4A (HCT cells)</ref>).</s><s>This subunit dependence resembled that observed with cellular carboplatin and cisplatin resistance (Figs <ref type="table">1 and EV2</ref>).</s><s>The LRRC8-dependent uptake component increased with variable time course over the first few hours <ref type="bibr">(Figs 6C and E,</ref><ref type="bibr">EV4A and EV5)</ref>.</s><s>When uptake was studied in isotonic saline for 1 h or less, no significant influence of either LRRC8A or LRRC8D was detected <ref type="bibr">(Fig 6D and E,</ref><ref type="bibr">highlighted by dashed line,</ref><ref type="bibr">and Fig EV4B)</ref>.</s><s>Isotonic cisplatin uptake thus appears to be associated with a rather slow activation of VRAC in these cells, which we ( <ref type="table">Fig 5) and others (Shimizu et al, 2004; Poulsen et al, 2010; Min</ref>  <ref type="bibr">et al, 2011;</ref><ref type="bibr" target="#b9">Cai et al, 2015)</ref> have observed in response to pro-apoptotic drugs.</s></p><p><s>Hypotonic cell swelling activates VRAC anion currents within a few minutes <ref type="bibr" target="#b39">(Nilius et al, 1997;</ref><ref type="bibr" target="#b58">Voss et al, 2014)</ref>  Whereas long-term isotonic uptake was almost as strongly reduced in LRRC8D À/À as in LRRC8A À/À cells, the hypotonicity-stimulated cisplatin uptake component was abolished in LRRC8A À/À cells, but reduced by only up to 50% in LRRC8D À/À cells (Figs 6D (HEK) and EV4B (HCT116)).</s><s>Like I Cl,vol <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>, swelling-induced cisplatin uptake was normal in</s></p><formula xml:id="formula_0">LRRC8C À/À cells (Fig 6D), abolished in LRRC8(B,C,D,E) À/À cells (which express only LRRC8A) (Appendix Fig S3)</formula><p><s>, and was suppressed by the VRAC inhibitor carbenoxolone <ref type="bibr" target="#b59">(Ye et al, 2009;</ref><ref type="bibr">Voss et al, 2014) (Fig 6B)</ref>.</s><s>These findings indicated that VRACs (LRRC8 heteromers) transport Pt-based drugs and suggest a special role of LRRC8D-containing channels.</s></p><p><s>VRACs might be hetero-hexamers of LRRC8 proteins <ref type="bibr">(Abascal &amp; Zardoya, 2012;</ref><ref type="bibr" target="#b58">Voss et al, 2014)</ref>, and HEK and HCT116 cells express all five LRRC8 genes (Fig <ref type="figure" target="#fig_0">EV1</ref>).</s><s>This suggests a highly heterogeneous VRAC population.</s><s>We reduced this complexity by studying LRRC8(B,D,E) À/À , LRRC8(B,C,E) À/À , and LRRC8(B,C,D) À/À cells that can only express LRRC8A/C, LRRC8A/D, and LRRC8A/E heteromeric channels, respectively.</s><s>Long-term, isotonic cisplatin accumulation by A/D-expressing cells was much larger than by LRRC8A À/À cells (Figs <ref type="table">6E and EV5</ref> VRAC Cl À currents are inhibited by cisplatin-DMSO complexes in a LRRC8D-dependent manner</s></p><p><s>In a high-throughput drug screen for VRAC transport inhibitors, in which compounds were routinely dissolved in DMSO, we identified cisplatin as putative VRAC blocker (data not shown).</s><s>However, suppression of I Cl,vol required DMSO, with which cisplatin forms adducts like Pt(NH 3 ) 2 (Cl)(DMSO) <ref type="bibr" target="#b17">(Fischer et al, 2008)</ref>.</s><s>Cisplatin-DMSO complexes inhibited native I Cl,vol of HEK cells in a dosedependent manner (Fig 7A <ref type="figure">)</ref>, but had no effect on currents of LRRC8D À/À cells (Fig <ref type="figure">7B</ref>).</s><s>Hence, differently composed LRRC8 channels can also differ in their pharmacology, and cisplatinconducting VRACs might be specifically targeted without abolishing I Cl,vol and cell volume regulation.</s></p><p><s>Swelling-induced release of the cellular osmolyte taurine depends on LRRC8D Whereas LRRC8D À/À cells displayed unchanged swelling-activated Cl À currents (I Cl,vol ) <ref type="bibr">(Figs 3A and B, and 6G;</ref><ref type="bibr" target="#b58">Voss et al, 2014)</ref>, their RVD was markedly decreased <ref type="bibr">(Fig 3C)</ref>.</s><s>We therefore hypothesized that LRRC8D is not only important for the transport of cis-and carboplatin, but also of organic osmolytes that do not contribute to electric currents.</s><s>Indeed, LRRC8D disruption drastically reduced swelling-induced efflux of the important cellular osmolyte taurine (Fig <ref type="figure">8A</ref>), but had less of an effect than disruption of LRRC8A that apparently totally abolishes swelling-induced taurine efflux <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>.</s><s>Transient transfection of LRRC8D, which is difficult to express heterologously <ref type="bibr" target="#b58">(Voss et al, 2014)</ref> A, B Cisplatin-induced caspase activity in the continuous presence of 200 lM cisplatin under isotonic conditions (A), or after 1 h exposure to 200 lM cisplatin under iso-and hypotonic conditions (B), was followed over time in WT, LRRC8A À/À , LRRC8D À/À , and LRRC8 À/À HCT116 cells.</s><s>Results from LRRC8A À/À and LRRC8D À/À were obtained with two different clonal cell lines each and averaged.</s><s>C</s></p><p><s>Caspase activation after 1-h exposure to 4 lM staurosporine under isoor hypotonic conditions of WT, LRRC8A À/À , LRRC8D À/À , and LRRC8 À/À HCT116 cells.</s><s>preincubation and was abolished in LRRC8A À/À cells.</s><s>Taurine efflux did not occur through cell morbidity-related unspecific leaks since it could be blocked by carbenoxolone (Fig. <ref type="figure">8F</ref>).</s><s>WT VRACs seemed to transport taurine at low rates also without stimulation by cisplatin as indicated by the reduced efflux from cells lacking LRRC8A.</s><s>However, at these low transport rates, we cannot exclude that slight and variable osmotic imbalances marginally opened VRAC as steady-state efflux differed between experiments (compare Fig <ref type="figure">8A-E</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Our work indicates that heteromeric LRRC8 channels (VRACs) can transport cisplatin and carboplatin, widely used anti-cancer drugs, and that the substrate selectivity and pharmacology of VRAC depend on its subunit composition.</s><s>LRRC8D plays important pharmacological and physiological roles in supporting the transport of anti-cancer drugs and of the organic osmolyte taurine.</s><s>LRRC8 channels also facilitated drug-induced apoptosis independent of drug transport, revealing a dual role of VRAC in cisplatin toxicity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>LRRC8 channels in drug-induced apoptosis</head><p><s>Several groups have reported that inhibition of bona fide VRAC (VSOR, VSOAC) by various non-specific compounds impaired the induction of apoptosis by drugs such as cisplatin and staurosporine <ref type="bibr" target="#b36">(Maeno et al, 2000;</ref><ref type="bibr" target="#b24">Ise et al, 2005;</ref><ref type="bibr" target="#b41">Okada et al, 2006;</ref><ref type="bibr">d'Anglemont de Tassigny et al, 2008;</ref><ref type="bibr" target="#b47">Poulsen et al, 2010)</ref>.</s><s>These findings were attributed to an impairment of VRAC-dependent apoptotic volume decrease (AVD) which is thought to be crucial for the progression of apoptosis <ref type="bibr" target="#b36">(Maeno et al, 2000)</ref> (for recent reviews, see <ref type="bibr" target="#b21">Hoffmann &amp; Lambert, 2014;</ref><ref type="bibr" target="#b32">Lang &amp; Hoffmann, 2012)</ref>.</s><s>Indeed, cisplatin and other drugs lead to a slow activation of currents with typical characteristics of I Cl,vol , and the resulting AVD could be reduced by non-specific VRAC inhibitors <ref type="bibr" target="#b51">(Shimizu et al, 2004;</ref><ref type="bibr" target="#b47">Poulsen et al, 2010;</ref><ref type="bibr" target="#b38">Min et al, 2011;</ref><ref type="bibr" target="#b9">Cai et al, 2015)</ref>.</s><s>Moreover, several cancer drug-resistant cell lines display less I Cl,vol , AVD, RVD, and swellingactivated taurine efflux than their parent cells <ref type="bibr" target="#b34">(Lee et al, 2007;</ref><ref type="bibr" target="#b47">Poulsen et al, 2010;</ref><ref type="bibr" target="#b38">Min et al, 2011;</ref><ref type="bibr" target="#b53">Sørensen et al, 2014)</ref>.</s><s>In KCP-4 cells, both cisplatin sensitivity and I Cl,vol were partially restored in parallel by non-specific changes in gene expression using a histone deacetylase inhibitor <ref type="bibr" target="#b34">(Lee et al, 2007)</ref>.</s><s>Since some of those cell lines are resistant to various anti-cancer drugs that probably enter cells through different pathways, these reports suggested that VRAC downregulation entailed drug resistance through an AVD-dependent mechanism.</s></p><p><s>Because LRRC8A was required for both I Cl,vol and pro-apoptotic drug-induced iodide influx or taurine efflux, our data now strongly suggest that LRRC8 channels are involved in both RVD and AVD.</s><s>Since disruption of the obligatory VRAC subunit LRRC8A also reduced the activation of caspase-3 by two pro-apoptotic stimuli, staurosporine and cisplatin, our results are compatible with the notion that apoptosis is facilitated by an LRRC8A-dependent volume decrease.</s><s>The requirement for LRRC8D in cisplatin-induced, but not in staurosporine-induced caspase activation, can be explained by different mechanisms of cellular uptake.</s><s>Staurosporine, a large hydrophobic compound that may cross membranes by passive diffusion, apparently does not enter cells through VRAC since it activated caspases regardless of whether it was applied in iso-or hypotonic medium.</s><s>By contrast, cisplatin permeates through VRACs, in particular those containing LRRC8D subunits.</s><s>This uptake mechanism imposes an additional LRRC8D dependence on caspase induction by cisplatin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cisplatin and carboplatin uptake through VRAC</head><p><s>Like I Cl,vol and taurine efflux <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>, cellular cisplatin uptake was strongly stimulated by hypotonic swelling, as reported previously <ref type="bibr" target="#b52">(Smith &amp; Brock, 1989)</ref>.</s><s>This uptake component was abolished in LRRC8A À/À and LRRC8(B,C,D,E) À/À cells which do not express functional VRACs and was inhibited by the VRAC inhibitor carbenoxolone.</s><s>Furthermore, caspase activation by cisplatin showed a similar dependence on LRRC8 isoforms and medium tonicity as cisplatin uptake as is expected for an intracellular effect of cisplatin.</s><s>Our results, which were obtained with up to four different cell lines and several independent LRRC8 knockout clones that excluded off-target effects, constitute overwhelming evidence that LRRC8 channels directly transport cisplatin and carboplatin.</s></p><p><s>About 50 to 70% of long-term isotonic cisplatin uptake was dependent on LRRC8D and LRRC8A, respectively.</s><s>The uptake component remaining in LRRC8A À/À and LRRC8(B,C,D,E) À/À cells probably represents passive diffusion across the plasma membrane <ref type="bibr" target="#b19">(Gately &amp; Howell, 1993)</ref>.</s><s>The dependence on LRRC8D was surprising since this isoform is dispensable for I Cl,vol <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>.</s><s>Drug uptake through VRAC was also unexpected since this channel is thought to be closed under isotonic conditions <ref type="bibr" target="#b39">(Nilius et al, 1997)</ref>, which prevents a continuous loss of cellular constituents like amino acids.</s><s>However, LRRC8-dependent isotonic uptake of cisplatin in HEK cells developed with a time course that was ▸ Figure <ref type="figure">6</ref>.</s><s>LRRC8 subunit-and osmolarity-dependent carboplatin/cisplatin transport.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>A</head><p><s>Carboplatin uptake into control KBM7 cells and two LRRC8D-deficient clones (n = 6).</s><s>B Hypotonicity-stimulated cisplatin uptake in HEK WT cells was selectively blocked by 100 lM carbenoxolone (CBX), a non-specific blocker of VRAC (n = 3).</s><s>C, D Cisplatin uptake into HEK cells of indicated genotypes using 40 lM cisplatin under long-term isotonic (C) or 200 lM cisplatin in short-term hypo-and isotonic (D) conditions as function of time (n = 3).</s><s>Similar results were obtained in HCT116 cells (Fig <ref type="figure" target="#fig_4">EV4</ref>).</s><s>E, F Cisplatin uptake (200 lM) into HEK cells of indicated genotypes.</s><s>LRRC8(B,C,E) À/À and LRRC8(B,D,E) À/À cells express only LRRC8A and LRRC8D, and LRRC8A and LRRC8C, respectively (n = 3 for WT, 6 for LRRC8D À/À , 9 for LRRC8A À/À in E; n = 3 in F).</s><s>G Mean current densities of maximally activated I Cl,vol at À80 mV.</s><s>The number of cells is indicated for each column.</s><s>H Ratio of LRRC8-dependent swelling-activated cisplatin uptake (60 min) to mean I Cl,vol (as in G) as function of genotype.</s></p><p><s>Data information: Data are presented as mean AE SEM.</s><s>*P &lt; 0.05; **P &lt; 0.01; and ***P &lt; 0.001 (for (C, E) compared to LRRC8A À/À cells).</s><s>Dotted lines in (D) and (F) highlight that there is no significant difference in isotonic 60-min uptake between the genotypes.</s></p><p><s>The consistent with a slow drug-induced activation of VRAC.</s><s>Previously, the activation of bona fide VRAC channels or AVD by 5-15 lM cisplatin has been observed after time lags that ranged from ~20 min <ref type="bibr" target="#b38">(Min et al, 2011;</ref><ref type="bibr" target="#b9">Cai et al, 2015)</ref> to ~4 h <ref type="bibr" target="#b47">(Poulsen et al, 2010)</ref>.</s><s>The time course of drug-induced activation of LRRC8Adependent iodide and taurine fluxes observed here is consistent with those previous findings.</s><s>It appears that only a small fraction of VRAC is activated by pro-apoptotic stimuli because the observed iodide, taurine, and cisplatin transport rates were roughly an order of magnitude lower than those obtained with strong hypotonic stimuli.</s><s>This fits the low VRAC current amplitudes observed by others <ref type="bibr" target="#b51">(Shimizu et al, 2004)</ref> upon exposure of cells to pro-apoptotic drugs.</s></p><p><s>Our data suggest that cisplatin, after having entered cells through passive diffusion across the plasma membrane, opens VRAC as an additional pathway for its uptake.</s><s>This feedforward mechanism results in additional cisplatin-induced cisplatin uptake.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Dual role of LRRC8 in drug resistance: drug uptake and AVDrelated apoptosis</head><p><s>Many biochemical alterations result in resistance to Pt-based anticancer drugs of cultured cells, but it has remained unclear which proteins are involved in medically relevant Pt drug transport <ref type="bibr" target="#b3">(Borst et al, 2008;</ref><ref type="bibr" target="#b20">Hall et al, 2008;</ref><ref type="bibr" target="#b8">Burger et al, 2011;</ref><ref type="bibr" target="#b25">Ivy &amp; Kaplan, 2013)</ref>.</s><s>We now identified VRAC as a major uptake mechanism for cis-and carboplatin.</s><s>As VRACs mediated about half of isotonic cisplatin uptake, downregulation of LRRC8 subunits could have significant impact on tumor drug resistance.</s><s>While requiring confirmation by prospective studies, this notion is supported by our analysis of two independent data sets from ovarian cancer patients: LRRC8D downregulation correlated with poor survival of Pt drug-treated patients.</s></p><p><s>No correlation was seen with reduced LRRC8A expression, possibly because LRRC8A-dependent volume regulation is a viability factor for cells.</s></p><p><s>In addition to its role in cisplatin/carboplatin uptake, VRAC facilitated apoptosis through an independent, possibly AVD-related mechanism.</s><s>An impairment of apoptosis may further contribute to drug resistance <ref type="bibr" target="#b29">(Kelly &amp; Strasser, 2011;</ref><ref type="bibr" target="#b54">Speirs et al, 2011)</ref>, although tumor cells treated with therapeutic doses of Pt drugs probably die predominantly by other mechanisms <ref type="bibr" target="#b2">(Borst et al, 2001;</ref><ref type="bibr" target="#b6">Brown &amp; Wilson, 2003;</ref><ref type="bibr" target="#b7">Brown &amp; Attardi, 2005)</ref>.</s><s>Acute induction of apoptosis in HCT116 cells, as analyzed in Fig <ref type="figure" target="#fig_4">4</ref>, is thought to require cisplatin concentrations that are ~10-fold higher than therapeutic ones <ref type="bibr" target="#b1">(Berndtsson et al, 2007)</ref>.</s><s>Such an induction is independent of nuclear DNA damage <ref type="bibr" target="#b37">(Mandic et al, 2003)</ref> and depends on the production of reactive oxygen species (ROS) <ref type="bibr" target="#b1">(Berndtsson et al, 2007)</ref> which can activate VRACs <ref type="bibr" target="#b51">(Shimizu et al, 2004;</ref><ref type="bibr" target="#b57">Varela et al, 2004)</ref>.</s><s>Therefore, the relevance of VRACfacilitated apoptosis at therapeutic doses remains to be determined in tumors of patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>LRRC8D increases VRAC's permeability for cisplatin/carboplatin and taurine</head><p><s>Whereas the obligatory LRRC8A subunit is required for the surface expression of VRAC, no specific roles could be assigned so far to the other subunits, except for an influence on the kinetics of inactivation at non-physiological voltages <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>.</s><s>We have now discovered a role of LRRC8D in taurine and cisplatin/carboplatin transport that is biologically and medically important.</s><s>Although LRRC8D disruption did not decrease swelling-activated Cl cisplatin.</s><s>Possible roles of other subunits and subunit combinations remain to be explored.</s></p><p><s>A mere loss of LRRC8D-containing, cisplatin-preferring channels should have quantitatively similar effects on isotonic and hypotonic uptake.</s><s>However, whereas under long-term isotonic conditions, LRRC8D disruption reduced the LRRC8-dependent component (as defined by the difference between WT and LRRC8A À/À cells) by ~70%, the hypotonicity-stimulated cisplatin uptake component was diminished by only ~50% or less in LRRC8D À/À cells.</s><s>This disparity suggests a differential activation of LRRC8D-containing heteromers by pro-apoptotic drugs or cell swelling.</s></p><p><s>LRRC8D also plays a prominent physiological role.</s><s>It crucially determines VRAC's taurine permeability, but mirroring its role in cisplatin transport, it is not absolutely required for taurine transport.</s><s>Taurine, the cellular concentrations of which range from 5 to 50 mM, is an important cellular osmolyte and has several additional biological roles <ref type="bibr" target="#b31">(Lambert et al, 2015)</ref>.</s><s>LRRC8D À/À cells can now be used to estimate the contribution of organic osmolytes to cell volume regulation.</s><s>Our RVD experiments suggest that this contribution is substantial.</s><s>The simultaneous presence in the plasma membrane of VRACs incorporating or lacking LRRC8D subunits probably explains previous observations which suggested that the volume-regulated anion channel VRAC is molecularly distinct from a volume-sensitive organic osmolyte and anion channel VSOAC <ref type="bibr" target="#b30">(Lambert &amp; Hoffmann, 1994;</ref><ref type="bibr" target="#b55">Stutzin et al, 1999;</ref><ref type="bibr" target="#b50">Shennan, 2008)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Implications for the pore of VRACs</head><p><s>The dependence of the substrate selectivity on subunit composition is compelling evidence that LRRC8 heteromers form the VRAC pore.</s><s>The structural basis of VRAC selectivity is currently unknown.</s><s>Remarkably, VRACs are thought to display a substantial anion &gt; cation selectivity for inorganic ions <ref type="bibr" target="#b39">(Nilius et al, 1997)</ref>, while also transporting rather large organic substrates.</s><s>The radius of the VRAC pore has been estimated to be 0.6-0.7 nm <ref type="bibr" target="#b15">(Droogmans et al, 1999;</ref><ref type="bibr" target="#b56">Ternovsky et al, 2004)</ref>.</s><s>This value is compatible with the release of organic osmolytes like taurine and amino acids and also with the uptake of cisplatin and carboplatin (maximal radius of ~0.15 and ~0.28 nm, respectively).</s><s>On the other hand, this simple consideration does not explain the observation that oxaliplatin (r ~0.45 nm) did not permeate, whereas blasticidin S (r ~0.7 nm) apparently does <ref type="bibr" target="#b35">(Lee et al, 2014)</ref>.</s></p><p><s>The conundrum of a highly halide-selective pore that also conducts much larger and differently charged organic substrates rests on the assumption that there is just one VRAC, and not a whole spectrum of differently composed LRRC8 heteromers, that is, different VRACs.</s><s>Given the wide tissue distribution of most LRRC8 isoforms, it is likely that various VRACs with diverse properties are co-expressed in the same cell.</s><s>Our work is compatible with the possibility that some subunit combinations form channels that only conduct organic substrates, whereas others only conduct small anions.</s><s>However, since, for example, LRRC8(B,C,E) À/À cells transport both organic molecules and Cl À , this hypothesis demands that LRRC8A and LRRC8D can assemble with different stoichiometries and thereby yield channels with different substrate selectivities.</s><s>This proposition, which could apply for other subunit combinations as well, is difficult to test.</s></p><p><s>Our work revealed that the specific subunit composition of VRACs determines their substrate specificity, regulation, and pharmacology.</s><s>LRRC8A/LRRC8D-containing VRACs, which are amenable to specific pharmacological modulation, are important for cell volume regulation by organic osmolytes.</s><s>They may also play an important dual role in tumor drug sensitivity by mediating cisplatin/ carboplatin uptake and possibly by modulating the progression of apoptosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Loss-of-function screens</head><p><s>A haploid-genetic screen for carboplatin resistance was performed as described <ref type="bibr" target="#b13">(Carette et al, 2011)</ref>.</s><s>10 8 KBM7 cells were transduced with a gene-trap retrovirus using spin infection.</s><s>10 8 mutagenized cells were then exposed to 7 lM carboplatin and distributed over 96-well plates (10 5 cells/well).</s><s>Surviving clones were pooled after 21 days and subjected to density centrifugation using lymphocyte separation medium (Lonza, 30 min at 400 g) to remove cell debris.</s><s>Next, 3 × 10 7 cells were pelleted for genomic DNA isolation (QiaAmp DNA mini kit, Qiagen).</s><s>Gene-trap insertion sites were amplified by inverse PCR.</s><s>First, genomic DNA was digested using the restriction enzymes NlaIII and MseI (New England Biolabs) overnight at 37°C.</s><s>Fragments were then circularized using T4 DNA ligase (New England Biolabs) (o/n at RT). Fragments containing the gene-trap sequence and flanking genomic DNA were amplified by PCR using primers containing the Illumina adapters P5 and P7 (for NlaIII-digested DNA: 5 0 -AATGATACGGCGACCACCGAGATCTGAT GGTTCTCTAGCTTGCC-3 0 and 5 0 -CAAGCAGAAGACGGCATACGAC CCAGGTTAAGATCAAGGTC-3 0 ; for MseI-digested DNA: 5 0 -AATGAT ACGGCGACCACCGAGATCTGATGGTTCTCTAGCTTGCC-3 0 and 5 0 -CAAGCAGAAGACGGCATACGACGTTCTGTGTTGTCTCTGTCTG-3 0 ).</s></p><p><s>Products were purified (PCR purification kit, Qiagen) and sequenced on a HiSeq 2000 (Illumina) using a custom sequencing primer 5 0 -CTAGCTTGCCAAACCTACAGGTGGGGTCTTTCA-3 0 .</s></p><p><s>Sequence reads were cropped to 36 bp for comparability with previously performed screens and aligned to the human genome (hg18) using bowtie <ref type="bibr" target="#b33">(Langmead et al, 2009)</ref>.</s><s>Only reads that align uniquely without mismatches were considered.</s><s>Additionally, reads aligning non-uniquely when 1 to 3 mismatches were allowed were removed, as well as reads falling within 2-bp distance of each other.</s><s>As the gene-trap construct is unidirectional, only insertion sites in the sense orientation of intronic regions, and integrations in sense or antisense of exonic sequences were considered.</s><s>To identify genes enriched in mutations following carboplatin treatment, the number of insertion sites per gene was compared to an unselected mutagenized population <ref type="bibr" target="#b13">(Carette et al, 2011)</ref> using a one-sided Fisher exact test.</s><s>Correction for multiple testing for P-values was carried out using Benjamini and Hochberg FDR correction in R.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cytotoxicity and colony formation assays</head><p><s>LRRC8D-expressing and LRRC8D-deficient KBM7 cells were seeded in 96-well plates in triplicates (3 × 10 5 cells per well) and treated with various concentrations of carboplatin, cisplatin, and oxaliplatin for 96 h.</s><s>Relative numbers of viable cells were measured in comparison with the untreated control and the solvent control using the fluorimetrical, resazurin-based Cell Titer Blue â assay (Promega).</s><s>Measurements were performed according to the manufacturer's instructions at 560Ex/590Em nm in a Tecan counter (Infinite M200).</s><s>Cell growth was expressed as percentage of the untreated control.</s></p><p><s>Regarding HAP1 cells, 10,000 LRRC8A À/À HAP1 and 8,000 HAP1 vector control cells were seeded per well into 6-well plates to account for differences in growth rate.</s><s>Cells were assayed for colony formation in the presence of five different concentrations of carboplatin, cisplatin, or oxaliplatin.</s><s>After 7 days, surviving colonies were formalin-fixed and stained with crystal violet.</s><s>The optical absorption was determined at 590 nm after extracting the dye with 10% acetic acid.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>LRRC8 knockout cell lines</head><p><s>The generation of stably diploid HCT116 cells and polyploid HEK293 cells with disruptions in one or several LRRC8 genes using the CRISPR-Cas9 method has been described previously <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>.</s><s>HEK cells lacking LRRC8A-E singly or in various combinations, and HAP1 cells lacking LRRC8A or LRRC8D, were newly generated using the same procedure.</s><s>KBM7 clones lacking LRRC8D were obtained from Hidde Ploegh <ref type="bibr" target="#b35">(Lee et al, 2014)</ref>.</s><s>Disruption of LRRC8 genes was confirmed by genomic sequencing and Western blotting <ref type="bibr">(Fig EV1)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Antibodies and Western blots</head><p><s>Polyclonal rabbit antibodies against LRRC8A and LRRC8E have been described previously <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>.</s><s>New antibodies were raised against LRRC8B, LRRC8C and LRRC8D in rabbits using the following peptides that were coupled through N-terminally added cysteines to keyhole limpet hemocyanin: QSLPYPQPGLESPGIESPT, LRRC8B; EDALFETLPSDVREQMKAD, LRRC8C; LEVKEALNQDVN VPFANGI, LRRC8D.</s><s>Sera were purified by affinity to the respective peptides.</s><s>Western blots of native HCT116 and HEK cells, together with cells lacking the respective LRRC8 isoforms, confirmed the specificity of the antisera, even though some sera (a-LRRC8C, a-LRRC8D) were made against mouse peptide sequences that differed by a few amino acids from the human counterparts.</s><s>Western blots were done following standard procedures using antibodies against tubulin or actin as loading controls.</s></p><p><s>Electrophysiology VRAC-mediated swelling-activated anion currents I Cl,vol were measured in the whole-cell patch-clamp configuration as described <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>.</s><s>Cells were swollen by exposure to hypotonic solution (240 mOsm) that differed from the isotonic solution (320 mOsm: 150 NaCl, 6 KCl, 1 MgCl 2 , 1.5 CaCl 2 , 10 glucose, and 10 HEPES, pH 7.4) by containing 105 instead of 150 mM NaCl.</s><s>In order to isolate Cl À currents, the pipette solution contained (in mM) the following: 40 CsCl, 100 Cs-methanesulfonate, 1 MgCl 2 , 1.9 CaCl 2 , 5 EGTA, 4 Na 2 ATP, and 10 HEPES, pH 7.2 (290 mOsm).</s><s>Whole-cell currents were monitored by voltage ramps from À100 to +100 mV and voltage-clamp traces recorded using the protocol shown in Fig <ref type="figure" target="#fig_3">3A</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurement of regulatory volume decrease (RVD)</head><p><s>Cell volume regulation was measured semiquantitatively using the calcein method (Capo ´-Aponte et al, 2005) in a fluorometric imaging plate reader (FLIPR TM ; Molecular Devices) in a 384-well format as described <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>.</s><s>Cell swelling was initiated by decreasing extracellular osmolarity to 94 mOsm, and calcein fluorescence was followed at k = 515-575 nm for ~65 min.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Drug-induced iodide influx</head><p><s>Iodide influx into HEK cells expressing an iodide-sensitive YFP variant <ref type="bibr" target="#b18">(Galietta et al, 2001)</ref> was carried out using the FLIPR TM as described <ref type="bibr" target="#b58">(Voss et al, 2014)</ref>, but using both LRRC8A +/+ and LRRC8A À/À cells.</s><s>Cells in half of the wells of 384-well plates were preincubated with 4 lM staurosporine (in 0.4% DMSO; also added to control wells) or 200 lM cisplatin (without DMSO) for the times indicated in Fig 7 <ref type="figure">.</ref></s><s>Iodide uptake (always under isotonic conditions) was initiated by pipetting 25 ll of a solution containing 70 mM iodide to the well, resulting in a final iodide concentration of 50 mM.</s><s>YFP quenching was followed over time using illumination at k = 495-505 nm and fluorescence measurement at k = 526-585 nm using the Fluo3 LED/filter set.</s><s>Maximal fluorescence quenching rates were determined as semiquantitative measure of iodide uptake.</s><s>Values were averaged from 16 wells for each condition.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Caspase-3 activity determination</head><p><s>Cells covering (~90% confluency) the bottom of 6-cm plates were incubated at 37°C/5% CO 2 in DMEM/FCS containing 4 lM staurosporine, or 0.4% DMSO as vehicle control, or 200 lM cisplatin (without DMSO).</s><s>Cells were collected at different times of drug exposure.</s><s>To explore the dependence on osmolarity, cells were incubated with 4 lM staurosporine or 200 lM cisplatin in isotonic (320 mOsm) or hypotonic (240 mOsm) solution (as described for electrophysiology) for 1 h at 37°C.</s><s>The drug-containing solutions were then replaced by normal medium and cells incubated for different times.</s><s>Caspase activity from cytosolic extracts was monitored fluorometrically in a Safire2 plate reader (Tecan AG, CH) set at 37°C using as substrate 30 lM Ac-DEVD-AMC (Enzo).</s><s>Specific enzymatic activity was calculated from the slopes of the best fit curves and normalized to total protein.</s><s>For long-term isotonic protocols, the activity was further normalized to "time zero" samples.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Measurement of taurine efflux</head><p><s>HEK293 cells were grown to ~80% confluency (48-72 h after plating) in 35-mm diameter plates coated with poly-L-lysine.</s><s>For rescue experiments, cells were transfected one day before flux measurements with an LRRC8D expression plasmid using Fugene HD.</s><s>WT and LRRC8D À/À control cells were mock transfected with a GFP expression vector.</s><s>Cells were loaded with 3 [H]-taurine (2 lCi/ml; Hartmann Analytics) for 2 to 2.5 h in culture medium (without FCS) at 37°C.</s><s>They were then washed five times at room temperature with isotonic solution (same as used in electrophysiology).</s><s>After washing, external media were removed in 5-min intervals and replaced with fresh isotonic or hypotonic solution (same as in electrophysiology) and saved for counting.</s><s>To measure cisplatin-induced taurine efflux, cells were preincubated with cisplatin (200 lM) in cell culture medium for 2 or 10 h.</s><s>Cells were then loaded with 3 [H]-taurine for 2 h in cell culture medium (AE200 lM cisplatin, w/o FCS and w/o DMSO) at 37°C.</s><s>Cells were washed 5 times and incubated for 30 min at 37°C with fresh isotonic solution.</s><s>As a control for LRRC8 contribution to cisplatin-induced taurine efflux, isotonic solution containing 100 lM carbenoxolone was used throughout the washes.</s><s>At the end of the experiments, cells were lysed with 0.75 ml of 0.1 M NaOH.</s><s>The radioactivity of cell supernatants and of the final cell lysate was determined in a liquid scintillation counter.</s><s>Rate constants were calculated as previously described <ref type="bibr" target="#b22">(Holm et al, 2013)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Uptake of cisplatin into cells</head><p><s>Intracellular platinum drug concentrations were measured as described <ref type="bibr" target="#b4">(Brouwers et al, 2005)</ref> or by ICP-MS <ref type="bibr" target="#b5">(Brouwers et al, 2006)</ref> (NKI and Institut fu ¨r Medizinische Diagnostik (IMD), Berlin).</s><s>Cells in 6-cm plates (~90% confluency) were incubated at 37°C/5% CO 2 in DMEM/FCS containing cisplatin (without DMSO) for different times as indicated.</s><s>For determining the dependence of uptake on osmolarity, cells were incubated with 200 lM cisplatin in isotonic or hypotonic solution (same as used in electrophysiology) for the indicated time periods at 37°C.</s><s>At the end of the uptake period, cells were quickly washed 5 times with 3 ml ice-cold PBS, collected, gently spun down (1,000 g, 5 min, 4°C), and the pellet was resuspended in 0.1 M HCl.</s><s>For carboplatin uptake in KBM7 cells grown in suspension, 2 × 10 7 cells per group (in T25 flasks) were incubated at 37°C/5% CO 2 in IMDM Glutamax (10% FBS) containing 7 lM carboplatin (without DMSO) and samples were collected at the indicated time points after drug treatment.</s><s>Cells were quickly washed twice with 10 ml cold PBS (400 g, 5 min), and the pellet was resuspended in 1 ml cold PBS.</s><s>Of this suspension, 100 ll was taken for protein concentration determination using the BCA assay.</s><s>The rest (900 ll) was spun down (400 g, 5 min) and resuspended in 200 ll 0.1 M HCL for ICP-MS.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gene expression and survival analysis based on published data concerning ovarian cancer patients</head><p><s>Gene expression data were downloaded from the TCGA (http://cancergenome.nih.gov/).</s><s>The expression data are derived from RNAseq with expression quantification using RSEM.</s><s>The density plot shows the log of the gene expression of the individual LRRC8 family members.</s><s>The survival analysis uses the clinical data provided by the TCGA.</s><s>The number of days to death is scored as an event.</s><s>As time interval definition, we used "days_to_last_follow-up."</s></p><p><s>This is the time interval from the date of last follow-up to the date of initial pathologic diagnosis, represented as a calculated number of days (https://tcga-data.nci.nih.gov/docs/dictionary/).</s><s>The patients were stratified on the expression levels of LRRC8A or LRRC8D.</s><s>Those that were in the lowest tertile (&lt; 33%) of the levels were classed as having low expression.</s><s>The analysis is performed with the package "survival" from the R-project.</s><s>The Australian ovarian cancer (OV AU) expression data of the study performed by <ref type="bibr" target="#b45">Patch et al (2015)</ref> were gene-wise matched to the TCGA panel after which the selected RSEM was normalized.</s><s>A survival analysis was performed contrasting the low (&lt; 33%) expression of LRRC8A or LRRC8D against the rest.</s></p><p><s>Expanded View for this article is available online.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Loss-of-function screen using haploid KBM7 cells identifies LRCC8A and LRRC8D as determinants of carboplatin resistance.</s></p></div></figDesc><graphic coords="3,45.34,76.52,507.26,503.08" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Low expression of LRRC8D but not LRRC8A correlates with shorter survival of high grade serous ovarian cancer patients treated with platinumbased drugs.</s><s>A-D Differential survival based on LRRC8A (A, C) or LRRC8D (B, D) gene expression as extracted from the TCGA database (http://cancergenome.nih.gov/)</s><s>(A, B) or using the data from Patch et al (2015) (C, D).</s><s>As cutoff the lower tertile of LRRC8A or LRRC8D gene expression was used.</s><s>P-values were determined using the log-rank test.</s></p></div></figDesc><graphic coords="4,42.49,77.36,509.02,401.59" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>(Appendix Fig S2A  and E).</s><s>A 25% decrease in osmolarity during 15-or 60-min uptake periods indeed increased cisplatin accumulation several-fold(Figs 6D and F (HEK), and EV4B, Appendix Fig S3 (HCT116)).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Disruption of LRRC8A, but not of LRRC8D, abolishes I Cl,vol and blocks volume regulation.</s><s>A, B VRAC currents (I Cl,vol ) of the HAP1 (A) and KBM7 (B) haploid cell lines.</s><s>Left panels, example current traces of I Cl,vol fully activated by hypotonic cell swelling measured with the voltage-clamp protocol shown in (A).</s><s>Dashed lines indicate zero current.</s><s>Right panels, averaged current/voltage relationships of maximally activated I Cl,vol .</s><s>Consistent with VRAC currents, they needed hypotonic swelling for activation, displayed an I À &gt; Cl À permeability sequence, and were blocked by DCPIB (Appendix Fig S2A-H).</s><s>The difference in current inactivation between HAP1 and KBM7 cells can be explained by the fact that KBM7 cells hardly express LRRC8E (Fig EV1) which accelerates VRAC inactivation (Voss et al, 2014).</s><s>At potentials &gt; +100 mV, also KBM7 currents inactivated (Appendix Fig S2I).</s><s>Data are presented as mean AE SEM; n = 5-10.</s><s>C Dependence of regulatory volume decrease (RVD) of HEK cells on LRRC8 genes.</s><s>Cells were exposed to hypotonic medium starting at t = 0, and intracellular calcein fluorescence was followed over ~1 h as semiquantitative measure of cell volume.</s><s>Data are presented as mean values AE SEM from sixteen wells.</s></p></div></figDesc><graphic coords="5,42.49,76.52,507.64,168.37" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>CFigure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4. LRRC8 subunit-and osmolarity-dependent caspase induction in HCT116 cells.</s></p></div></figDesc><graphic coords="6,43.87,76.52,244.12,553.69" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Figure 5 .</head><label>5</label><figDesc><div><p><s>Figure 5. Activation of LRRC8 channels by pro-apoptotic stimuli.</s><s>A-C Cisplatin-induced iodide influx into WT (black ■), but not LRRC8A À/À (green ▼) HEK cells indicates VRAC halide current activation during apoptosis.</s><s>Cells expressing an iodide-sensitive YFP variant were exposed to 200 lM cisplatin for periods of 0.5 h (A), 4.5 h (B), or 8.5 h (C) before adding extracellular I À (50 mM final).</s><s>The difference in slopes of YFP fluorescence quenching between control and cisplatin-treated cells semiquantitatively reflects VRAC current activation.</s><s>Note that increased YFP quenching with cisplatin preincubation is not due to large non-specific leaks resulting from cell morbidity.</s><s>Such leaks should lead to a fast component of YFP quenching in WT, but not LRRC8A À/À cells after the pipetting artifact that immediately follows addition of iodide (indicated by arrows).</s><s>D Swelling-induced iodide influx into WT (black ■) and LRRC8A À/À (green ▼) HEK cells for comparison.</s><s>Iodide (50 mM final) was added in isotonic or hypotonic (230 mOsm final) solution at the time indicated by arrow.</s><s>E, F Time course of VRAC activation by 200 lM cisplatin (E) or 4 lM staurosporine (F) determined as in (A-C).</s><s>Averaged maximal slopes of YFP quenching from eight wells (E) or 16 wells (F) each were evaluated to estimate iodide influx rates.</s><s>WT (black ■) and LRRC8A À/À (green ▼).</s><s>Data are presented as mean AE SEM.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head></head><label></label><figDesc><div><p><s>Figure6.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 7 .Figure 8 .</head><label>78</label><figDesc><div><p><s>Figure 7. Cisplatin-DMSO inhibition of I Cl,vol depends on the LRRC8D subunit.</s><s>A Upper panel, example current traces (as in Fig 3A) of fully activated I Cl,vol in HEK cells exposed to hypotonic solution containing vehicle (0.3% DMSO) or 200 lM cisplatin in 0.3% DMSO.</s><s>Dashed lines indicate zero current.</s><s>Lower panel, I Cl,vol current densities (at À100 mV and 100 mV) of WT HEK cells treated with different cisplatin concentrations.</s><s>B No effect of 200 lM cisplatin/DMSO on I Cl,vol in LRRC8D À/À HEK cells.</s><s>Data information: Data are presented as mean AE SEM; the number of experiments is given for each bar; *P &lt; 0.05; **P &lt; 0.01.</s></p></div></figDesc><graphic coords="10,44.17,76.52,243.40,341.74" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>ª</head><label></label><figDesc><div><p><s>2015 The Authors The EMBO Journal Vol 34 | No 24 | 2015</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head></head><label></label><figDesc><div><p><s>Data are presented as mean AE SEM, with n denoting the number of observations (samples).</s><s>For RVD measurements (Fig 3C), cisplatin uptake in Figs 6C-F and EV4, caspase induction (Fig 4A), activation of VRAC iodide flux (Fig 5), and Western blots (Fig EV1), a minimum of two independent experiments were performed with similar results.</s><s>Student's t-tests for paired or unpaired data were employed as appropriate and considered as significant as follows: *P &lt; 0.05; **P &lt; 0.01; and ***P &lt; 0.001.</s></p></div></figDesc></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank Carolin Backhaus, Andrea Weidlich, and Janet Liebold for technical</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author contributions</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of interest</head><p><s>The authors declare that they have no conflict of interest.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>References</head><p><s>Abascal F, Zardoya R ( <ref type="formula">2012</ref> The EMBO Journal Subunit-dependent drug and osmolyte flux via VRAC Rosa Planells-Cases et al</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2</title>
		<author>
			<persName><forename type="first">A</forename><surname>De Tassigny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Berdeaux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Souktani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Henry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ghaleh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="39" to="46" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Acute apoptosis by cisplatin requires induction of reactive oxygen species but is not associated with damage to nuclear DNA</title>
		<author>
			<persName><forename type="first">M</forename><surname>Berndtsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hagg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Panaretakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Havelka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Shoshan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Linder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="175" to="180" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Does resistance to apoptosis affect clinical response to antitumor drugs?</title>
		<author>
			<persName><forename type="first">P</forename><surname>Borst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Borst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Smets</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Resist Updat</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="129" to="131" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">How do real tumors become resistant to cisplatin?</title>
		<author>
			<persName><forename type="first">P</forename><surname>Borst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rottenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Jonkers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="1353" to="1359" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Determination of oxaliplatin in human plasma and plasma ultrafiltrate by graphite-furnace atomic-absorption spectrometry</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Brouwers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Tibben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Joerger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Van Tellingen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rosing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Schellens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Beijnen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Anal Bioanal Chem</title>
		<imprint>
			<biblScope unit="volume">382</biblScope>
			<biblScope unit="page" from="1484" to="1490" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Brouwers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Tibben</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Rosing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Hillebrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Joerger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Schellens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Beijnen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mass Spectrom</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="1186" to="1194" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Apoptosis genes and resistance to cancer therapy: what does the experimental and clinical data tell us?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cancer Biol Ther</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="477" to="490" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The role of apoptosis in cancer development and treatment response</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Attardi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="231" to="237" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Drug transporters of platinum-based anticancer agents and their clinical significance</title>
		<author>
			<persName><forename type="first">H</forename><surname>Burger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Loos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Eechoute</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Verweij</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Mathijssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Wiemer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Resist Updat</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="22" to="34" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Volume-sensitive chloride channels are involved in cisplatin treatment of osteosarcoma</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Med Rep</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="2465" to="2470" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Characterization of regulatory volume behavior by fluorescence quenching in human corneal epithelial cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Capó-Aponte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Iserovich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Reinach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Membr Biol</title>
		<imprint>
			<biblScope unit="volume">207</biblScope>
			<biblScope unit="page" from="11" to="22" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Carette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Guimarães</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Varadarajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wuethrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Godarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kotecki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Cochran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Spooner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Ploegh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Brummelkamp</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Haploid genetic screens in human cells identify host factors used by pathogens</title>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">326</biblScope>
			<biblScope unit="page" from="1231" to="1235" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Carette</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Guimarães</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Wuethrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">A</forename><surname>Blomen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Varadarajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Yuan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Muellner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Nijman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Ploegh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Brummelkamp</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Global gene disruption in human cells to assign genes to phenotypes by deep sequencing</title>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="542" to="546" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Sulphonic acid derivatives as probes of pore properties of volume-regulated anion channels in endothelial cells</title>
		<author>
			<persName><forename type="first">G</forename><surname>Droogmans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Maertens</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Prenen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nilius</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="35" to="40" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Restriction of cisplatin induction of acute apoptosis to a subpopulation of cells in a three-dimensional carcinoma culture model</title>
		<author>
			<persName><forename type="first">W</forename><surname>Fayad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Brnjic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Berglind</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Blixt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Shoshan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Berndtsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Olofsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Linder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cancer</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="2450" to="2455" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Cisplatin and dimethyl sulfoxide react to form an adducted compound with reduced cytotoxicity and neurotoxicity</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Benson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fauq</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Naylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Windebank</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurotoxicology</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="444" to="452" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Green fluorescent protein-based halide indicators with improved chloride and iodide affinities</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Galietta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Haggie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Verkman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">499</biblScope>
			<biblScope unit="page" from="220" to="224" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Cellular accumulation of the anticancer agent cisplatin: a review</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">P</forename><surname>Gately</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Howell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="1171" to="1176" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Hall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Okabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Gottesman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Annu Rev Pharmacol Toxicol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="495" to="535" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Ion channels and transporters in the development of drug resistance in cancer cells</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Lambert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Philos Trans R Soc Lond</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page">20130109</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Volume-sensitive release of organic osmolytes in the human lung epithelial cell line A549: role of the 5-lipoxygenase</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Holm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Grygorczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Lambert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="C48" to="C60" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">LRRC8A protein is indispensable for swelling-activated and ATP-induced release of excitatory amino acids in rat astrocytes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Hyzinski-García</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rudkouskaya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Mongin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Physiol</title>
		<imprint>
			<biblScope unit="volume">592</biblScope>
			<biblScope unit="page" from="4855" to="4862" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Roles of volumesensitive Cl À channel in cisplatin-induced apoptosis in human epidermoid cancer cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Inoue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Membr Biol</title>
		<imprint>
			<biblScope unit="volume">205</biblScope>
			<biblScope unit="page" from="139" to="145" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main">A re-evaluation of the role of hCTR1, the human high-affinity copper transporter</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Ivy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Kaplan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>in platinum-drug entry into human cells</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Mol Pharmacol</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="1237" to="1246" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Volume-sensitive anion channels mediate swelling-activated inositol and taurine efflux</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Jackson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Strange</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">265</biblScope>
			<biblScope unit="page" from="C1489" to="C1500" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The resurgence of platinum-based cancer chemotherapy</title>
		<author>
			<persName><forename type="first">L</forename><surname>Kelland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Cancer</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="573" to="584" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">The essential role of evasion from cell death in cancer</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Strasser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Cancer Res</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="39" to="96" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cell swelling activates separate taurine and chloride channels in Ehrlich mouse ascites tumor cells</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Hoffmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Membr Biol</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page" from="289" to="298" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Physiological role of taurine -from organism to organelle</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Kristensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Holm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">H</forename><surname>Mortensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Physiol (Oxf)</title>
		<imprint>
			<biblScope unit="volume">213</biblScope>
			<biblScope unit="page" from="191" to="212" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Role of ion transport in control of apoptotic cell death</title>
		<author>
			<persName><forename type="first">F</forename><surname>Lang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Hoffmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Compr Physiol</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="2037" to="2061" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Searching for SNPs with cloud computing</title>
		<author>
			<persName><forename type="first">B</forename><surname>Langmead</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Schatz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Salzberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Biol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">R134</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Impaired activity of volume-sensitive Cl À channel is involved in cisplatin resistance of cancer cells</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Numata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">211</biblScope>
			<biblScope unit="page" from="513" to="521" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">The protein synthesis inhibitor blasticidin S enters mammalian cells via leucine-rich repeatcontaining protein 8D</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Freinkman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Sabatini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Ploegh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="17124" to="17131" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Maeno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ishizaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kanaseki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hazama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">97</biblScope>
			<biblScope unit="page" from="9487" to="9492" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Cisplatin induces endoplasmic reticulum stress and nucleus-independent apoptotic signaling</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mandic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Linder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Shoshan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="9100" to="9106" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Dysfunction of volume-sensitive chloride channels contributes to cisplatin resistance in human lung adenocarcinoma cells</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Min</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Hou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Biol Med</title>
		<imprint>
			<biblScope unit="volume">236</biblScope>
			<biblScope unit="page" from="483" to="491" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Properties of volume-regulated anion channels in mammalian cells</title>
		<author>
			<persName><forename type="first">B</forename><surname>Nilius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Eggermont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Voets</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Buyse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Manolopoulos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Droogmans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog Biophys Mol Biol</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="69" to="119" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Volume expansion-sensing outward-rectifier Cl À channel: fresh start to the molecular identity and volume sensor</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Okada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">273</biblScope>
			<biblScope unit="page" from="C755" to="C789" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Y</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Maeno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Takahashi</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Volume-sensitive chloride channels involved in apoptotic volume decrease and cell death</title>
	</analytic>
	<monogr>
		<title level="j">J Membr Biol</title>
		<imprint>
			<biblScope unit="volume">209</biblScope>
			<biblScope unit="page" from="21" to="29" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">The Authors The EMBO Journal</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<date type="published" when="2015">2015. 2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Cell volume and monovalent ion transporters: their role in cell death machinery triggering and progression</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Orlov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Platonova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hamet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Grygorczyk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">305</biblScope>
			<biblScope unit="page" from="C361" to="C372" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Whole-genome characterization of chemoresistant ovarian cancer</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Patch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Christie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Etemadmoghadam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Garsed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>George</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fereday</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cowin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Alsop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Bailey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Kassahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Newell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Quinn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kazakoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Quek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wilhelm-Benartzi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Curry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Leong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hamilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mileshkin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">521</biblScope>
			<biblScope unit="page" from="489" to="494" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The identification of VRAC (Volume Regulated Anion Channel): an amazing Odyssey</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Pedersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Klausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nilius</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Physiol (Oxf)</title>
		<imprint>
			<biblScope unit="volume">213</biblScope>
			<biblScope unit="page" from="868" to="881" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title level="m" type="main">Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: role of chloride channels</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Poulsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Andersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Hansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Klausen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hougaard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Hoffmann</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">298</biblScope>
			<biblScope unit="page" from="C14" to="C25" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">SWELL1, a plasma membrane protein, is an essential component of volume-regulated anion channel</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Qiu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Dubin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mathur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Tu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Miraglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Reinhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Orth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Patapoutian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="447" to="458" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Swelling-induced taurine transport: relationship with chloride channels, anion-exchangers and other swelling-activated transport pathways</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Shennan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Physiol Biochem</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="15" to="28" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">A role of reactive oxygen species in apoptotic activation of volume-sensitive Cl À channel</title>
		<author>
			<persName><forename type="first">T</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Numata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okada</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="6770" to="6773" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">The effect of reduced osmolarity on platinum drug toxicity</title>
		<author>
			<persName><forename type="first">E</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Brock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="873" to="875" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Acquired cisplatin resistance in human ovarian A2780 cancer cells correlates with shift in taurine homeostasis and ability to volume regulate</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Sørensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">A</forename><surname>Thorsteinsdottir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Lambert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">307</biblScope>
			<biblScope unit="page" from="C1071" to="C1080" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Harnessing the cell death pathway for targeted cancer treatment</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Speirs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Varki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schleicher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cancer Res</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="43" to="61" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Separate taurine and chloride efflux pathways activated during regulatory volume decrease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Stutzin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Torres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Oporto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Pacheco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Eguiguren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Cid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">V</forename><surname>Sepúlveda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="C392" to="C402" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Sizing the pore of the volumesensitive anion channel by differential polymer partitioning</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">I</forename><surname>Ternovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">Z</forename><surname>Sabirov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">576</biblScope>
			<biblScope unit="page" from="433" to="436" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">NAD(P)H oxidasederived H 2 O 2 signals chloride channel activation in cell volume regulation and cell proliferation</title>
		<author>
			<persName><forename type="first">D</forename><surname>Varela</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Riveros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Jørgensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stutzin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope unit="page" from="13301" to="13304" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Identification of LRRC8 heteromers as an essential component of the volume-regulated anion channel VRAC</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Voss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Ullrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Münch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lazarow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lutter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Andrade-Navarro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Von</forename><surname>Kries</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Stauber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jentsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">344</biblScope>
			<biblScope unit="page" from="634" to="638" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Pharmacological &quot;cross-inhibition&quot; of connexin hemichannels and swelling activated anion channels</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">C</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Oberheim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kettenmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Ransom</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Glia</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="258" to="269" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
